Lineage Cell Therapeutics, Inc. (LCTX)
1.735
+0.10
(+5.79%)
USD |
NYAM |
Apr 17, 15:26
Lineage Cell Therapeutics Max Drawdown (5Y) : 87.55% for March 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| The Cooper Cos., Inc. | 45.45% |
| Pacira Biosciences, Inc. | 85.67% |
| OptimizeRx Corp. | 96.10% |
| Nutex Health, Inc. | 99.93% |
| Prime Medicine, Inc. | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -26.58 |
| Beta (5Y) | 1.795 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 62.53% |
| Historical Sharpe Ratio (5Y) | -0.1765 |
| Historical Sortino (5Y) | -0.3503 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.74% |